(Q38024857)

27 August 2017

Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV). (English)

1 reference

Japanese encephalitis virus

27 August 2017

0 references

Japanese encephalitis

1 reference

1 reference

Mohan Babu Appaiahgari

series ordinal

1

1 reference

PubMed ID

22775524

27 August 2017

Sudhanshu Vrati

series ordinal

2

1 reference

PubMed ID

22775524

27 August 2017

language of work or name

English

0 references

publication date

9 July 2012

1 reference

Expert Opinion on Biological Therapy

27 August 2017

1 reference

27 August 2017

12

1 reference

27 August 2017

9

1 reference

27 August 2017

1251-1263

1 reference

The epidemiology of Japanese encephalitis: prospects for prevention

27 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

The natural history of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Protection against Japanese encephalitis by inactivated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Neurological complications and Japanese encephalitis vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Allergic mucocutaneous reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Side-effects with Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Anaphylaxis to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

New developments in flavivirus vaccines with special attention to yellow fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

High fidelity of yellow fever virus RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.704908

10.1517/14712598.2012.704908

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22775524